TrialThe oncologist2020

A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).

Kaushal Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.